Kiniksa Pharmaceuticals Ltd (KNSA) — Free Cash Flow Generation Index
Kiniksa Pharmaceuticals Ltd (KNSA) has a Free Cash Flow Generation Index of 0.99x as of June 2026. Free cash flow of $46.80 Million represents 1% of operating cash flow ($47.46 Million). Explore reinvestment intensity of Kiniksa Pharmaceuticals Ltd to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Kiniksa Pharmaceuticals Ltd Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for Kiniksa Pharmaceuticals Ltd across 4 annual periods. For the full cash flow conversion analysis, see KNSA operating cash flow.
Annual Free Cash Flow Generation for Kiniksa Pharmaceuticals Ltd (2022–2025)
Year-by-year Free Cash Flow Generation Index for Kiniksa Pharmaceuticals Ltd. Check KNSA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.99x | $25.41 Million | $25.69 Million | $277.00K | ▲ +0.0% |
| 2024 | 0.99x | $25.41 Million | $25.69 Million | $277.00K | ▼ -0.1% |
| 2023 | 0.99x | $13.17 Million | $13.30 Million | $130.00K | ▲ +0.8% |
| 2022 | 0.98x | $5.70 Million | $5.81 Million | $105.00K | — |